SCHEMBL8684343

SCHEMBL8684343

CCOC(=O)Cn1ccn2nc(-c3ccccc3)cc12

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.57
▸ ALDH1A1 P00352 6/20 0.51
▸ TSHR P16473 3/20 0.49
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ KDM4E B2RXH2 3/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ POLB P06746 2/20 0.46
▸ GAA P10253 1/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5282599 0.78 HTT (0.64) HTTALDH1A1TSHRMEN1KMT2A
SCHEMBL5324181 0.76 HTT (0.74) HTTALDH1A1TSHRMEN1KMT2A
SCHEMBL9299345 0.76 ALDH1A1 (0.43) ALDH1A1TSHRKDM4ESMN1; SMN2POLB
SCHEMBL15656249 0.74 ALDH1A1 (0.77) HTTALDH1A1TSHRMEN1KMT2A
SCHEMBL22234295 0.72 ESR1 (0.57) HTTALDH1A1TSHRMEN1KMT2A
SCHEMBL1126957 0.72 ALDH1A1 (0.50) HTTALDH1A1TSHRMEN1KMT2A
SCHEMBL13307806 0.71 MEN1 (0.68) HTTALDH1A1TSHRMEN1KMT2A
SCHEMBL5966757 0.71 HTT (0.52) HTTALDH1A1TSHRMEN1KMT2A
SCHEMBL15654670 0.71 HTT (0.65) HTTALDH1A1TSHRMEN1KMT2A
SCHEMBL2049182 0.70 ALDH1A1 (0.65) HTTALDH1A1TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5723481-A ANTIULCER AGENTS AND 5-LIPOXYGENASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1998-03-03 — — US disclosed
US-5698576-A POSSESS ANTI-ULCER AND 5-LIPOXYGENASE INHIBITORY ACTIVITIES SANKYO COMPANY, LIMITED (JP) 1997-12-16 — — US disclosed
US-5665752-A LIPOXYGENASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1997-09-09 — — US disclosed
US-5354768-A Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO COMPANY, LIMITED (JP) 1994-10-11 — — US disclosed
EP-0353047-B1 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO CO (JP) 1994-10-05 — — EP disclosed
US-5232939-A Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO COMPANY LIMITED (JP) 1993-08-03 — — US disclosed
EP-0353047-A2 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents Sankyo Company Limited (JP) 1990-01-31 — — EP disclosed
Send feedback